From Apple Event: Now Discussing HomePod Mini In New Colors

https://www.apple.com/apple-events/event-stream/?&cid=wwa-us-kwgo-features-slid–Brand-AppleLive-Pre-&mtid=20925e1t39169&aosid=p238&mnid=sBi1b7IZ7-dc_mtid_20925e1t39169_pcrid_552517382314_pgrid_1256182688

byBenzinga Newsdesk

October 18, 2021

1 minute read

Cvent Holding Q2 EPS $(0.07) Misses $0.02 Estimate, Sales $161.00M Beat $153.78M Estimate

By Bill Haddad

August 4, 5:54 PM

Cvent Holding (NASDAQ:CVT) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.02 by 450 percent. The company reported quarterly sales of $161.00 million which beat the

CVT

FDA
News

Neuronetics Receives FDA 510(k) Premarket Notification Clearance For The Neurostar TMS Therapy System For Mental Health

By Benzinga Newsdesk

July 18, 11:26 AM

accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K220127

STIM

Biohaven Reports Enrollment Of Phase 1a/1b Trial Of BHV-110 In Combo With Natural Killer Cell Therapy For Treatment Of Multiple Myeloma

By Benzinga Newsdesk

October 27, 7:41 AM

-- Biohaven initiates a clinical trial of the novel antibody recruiting molecule BHV-1100 to assess safety, tolerability, and exploratory clinical activity in Multiple Myeloma -- BHV-1100 targets the destruction of

BHVN

Legal
News

Today Announced The U.S. District Court Of Delaware Issued An Oral Order In The Matter Of Salix Pharmaceuticals, Ltd. Et Al V. Norwich Pharmaceuticals

By Benzinga Newsdesk

July 28, 3:48 PM

Bausch Health Companies Inc. (TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, today announced the U.S. District Court of Delaware issued an Oral Order in the matter of Salix

BHC

From Apple Event: Now Discussing HomePod Mini In New Colors

Related Posts

Cvent Holding Q2 EPS $(0.07) Misses $0.02 Estimate, Sales $161.00M Beat $153.78M Estimate

Neuronetics Receives FDA 510(k) Premarket Notification Clearance For The Neurostar TMS Therapy System For Mental Health

Biohaven Reports Enrollment Of Phase 1a/1b Trial Of BHV-110 In Combo With Natural Killer Cell Therapy For Treatment Of Multiple Myeloma

Today Announced The U.S. District Court Of Delaware Issued An Oral Order In The Matter Of Salix Pharmaceuticals, Ltd. Et Al V. Norwich Pharmaceuticals